Medicine Man Technologies

SHWZ · OTC

$0.00+$0.00 (+900.00%)TodayMarket closed · Sep 29, 12:00 PM ET

No price history for this range.

SHWZ analyst rating

This isn't available right now. Refresh to try again.

The case for and against

Updated Nov 30, 2024

Bull case

Medicine Man Technologies Inc. demonstrates a positive outlook due to its ability to achieve a 4% year-over-year revenue increase, reflecting effective operational strategies amidst a competitive market. The company has notably expanded its retail presence to 63 dispensaries and reported a strong 31% adjusted EBITDA margin, indicating robust profitability. Additionally, with significant growth in the wholesale segment, including a 28% sequential increase in units sold, Medicine Man Technologies is well-positioned to capitalize on the expanding cannabis market.

Bear case

Medicine Man Technologies Inc. reported a significant decline in AEBITDA, with figures dropping to $7.3 million from $14.5 million year-over-year, largely attributed to decreased gross margins and increased operating expenses connected to the expansion phase of 21 new stores. The company’s operating cash flow turned negative, reaching $(3.7) million compared to $(0.88) million in the prior year, indicating escalating financial strain. Furthermore, regulatory challenges from the New Mexico Cannabis Control Division led to over 70 store closures and intensified competitive pressures in key markets, further exacerbating the company's profitability issues and contributing to an overall negative outlook.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.